Health & Biotech
Stories by Tim Boreham
Health & Biotech
HealthKick Podcast: Life sciences expert on local medical innovations, tech leaders and sector opportunities
Health & Biotech
HealthKick Podcast: ASX biotech Dimerix gains momentum from involvement in multiple COVID-19 studies
Health & Biotech
Dr Boreham’s Crucible: Breaking down ASX aspirant Artrya’s AI heart disease warning system
Health & Biotech
Dr Boreham’s Crucible: Breaking down the post-COVID market opportunity for Uscom
Health & Biotech
Dr Boreham’s Crucible: 4 ASX stocks focused on a mind-altering $25 billion psilocybin market
Health & Biotech
Dr Boreham’s Crucible: Testing times for Covid assay developers
Health & Biotech
Dr Boreham’s Crucible: Is the end of painful biopsies in BCal Diagnostics’ blood?
Health & Biotech
Dr Boreham’s Crucible: The reality of IDT Australia actually getting a COVID vaccine in a vial
Health & Biotech
Health Kick Podcast: How TALi Digital is using gamification to spot attention deficit issues in children
Health & Biotech
Dr Boreham’s Crucible: With five trials and $100m, cancer-hunter Clarity’s future is clear
Health & Biotech